The nahR gene of plasmid NAH7 of Pseudomonas putida encodes a 36-kilodalton polypeptide which activates transcription of the nah and sal operons in response to the inducer salicylate. A gel mobility shift assay was used to identify a DNA-binding activity which was present only in extracts from either P. putida or Escherichia coli containing a functional nahR gene. The binding activity was highly specific for DNA containing the nah or sal promoters, but the apparent affinity for the promoters was not altered by the presence of salicylate. DNase I protection experiments with a partially purified NahR protein preparation showed that NahR protects both nah and sal promoter sequences between -82 and -47. The location and amount of protection were not dramatically altered by the presence of salicylate. In vitro mutagenesis was used to make mutations in the protected region of the sal promoter. Analysis of the mutants showed that binding of NahR is required for transcription activation and identified two nucleotides in the protected region that are essential for binding and activation by NahR.
The nahR gene of plasmid NAH7 of Pseudomonas putida encodes a 36-kilodalton polypeptide which activates transcription of the nah and sal operons in response to the inducer salicylate. A gel mobility shift assay was used to identify a DNA-binding activity which was present only in extracts from either P. putida or Escherichia coli containing a functional nahR gene. The binding activity was highly specific for DNA containing the nah or sal promoters, but the apparent affinity for the promoters was not altered by the presence of salicylate. DNase I protection experiments with a partially purified NahR protein preparation showed that NahR protects both nah and sal promoter sequences between -82 and -47. The location and amount of protection were not dramatically altered by the presence of salicylate. In vitro mutagenesis was used to make mutations in the protected region of the sal promoter. Analysis of the mutants showed that binding of NahR is required for transcription activation and identified two nucleotides in the protected region that are essential for binding and activation by NahR.
The self-transmissible NAH7 plasmid of Pseudomonas putida encodes the enzymes for metabolism of naphthalene or salicylate as sole carbon and energy source (3) . The genes encoding these enzymes are located in two operons, nah and sal, both of which are coordinately induced at least 20-fold by salicylate (1, 28) . Induction requires the product of only one regulatory gene, nahR, and the presence of salicylate (21, 29) . Analysis of transcription of the operons in P. putida has shown that nahR acts in trans by constitutively producing an activator which enhances transcription of both nah and sal in response to salicylate (21) (22) (23) . The activation of the nah or sal promoters by nahR also occurs in the heterologous host Escherichia coli (23, 24) , indicating that E. coli RNA polymerase can specifically recognize some Pseudomonas promoters and be stimulated by NahR plus salicylate.
The nahR gene has been mapped, cloned, and shown to encode a 36-kilodalton polypeptide (24) . The nah and sal promoters (Punah and Pl,, respectively) have been located and sequenced, and a 21-base-pair (bp) region of remarkable homology (80%), located between -80 and -60 before the transcription start sites, has been found in both promoters (22) . Analysis of plasmids with various portions of Ps,, transcriptionally fused to the E. coli galK gene has shown that the sequence of the sal promoter between -83 and -45 is required for activation of transcription by the nahR gene in the presence of salicylate (24) . In addition, this same region contains the transcription start site and -10 sequence of the divergent nahR promoter and thus may also be involved in autoregulation of nahR (22) (23) (24) . Although binding of the nahR gene product (NahR) to this region is likely, demonstration of its specific binding is lacking.
Current knowledge of the molecular mechanisms involved in ligand-induced transcription activation in procaryotes is largely derived from a few intensely studied E. coli systems (e.g., AraC protein and catabolite gene activator protein) (9, 18) . Activators usually bind just upstream of the RNA polymerase binding site of the promoters they regulate and are thought to act by increasing the rate of open complex * Corresponding author. 837 formation (9, 18) . The molecular mechanism by which the inducer stimulates the activator to increase open complex formation is not clear; both inducer-enhanced binding and conformational change of the activator have been implicated (7, 11) . Other transcription activation mechanisms involve alternate sigma factors (9) or binary regulatory gene systems (e.g., ompR-envZ or virA-virG) in which a sensory component activates a "dormant" transcriptional activator component in response to an inducer (25) . New inducer-responsive activator proteins are in the early stages of molecular analysis (e.g., MerR and NodD) (6, 8) .
To begin elucidation of the mechanism used by NahR protein, we have investigated its DNA-binding properties and nucleotide requirements for activation. Our results suggest that NahR is tightly bound upstream of the nah and sal promoters irrespective of the presence of salicylate, implicating inducer-stimulated conformational change in the activation mechanism.
MATERIALS AND METHODS Chemicals. All molecular biology reagents were purchased from Bethesda Research Laboratories, Inc., Gaithersburg, Md.; New England BioLabs, Inc., Beverly Mass,; or Boehringer Mannheim Biochemicals, Indianapolis, Ind. Media components were from Difco Laboratories, Detroit, Mich. T4 DNA polytnerase and nucleotide triphosphates were from P-L Biochemicals, Inc., Milwaukee, Wis. Antibiotics, electrophoresis chemicals, and other chemicals were from Sigma Chemical Co., St. Louis, Mo., or were of reagentgrade purity.
Bacterial strains and plasmids. Bacterial strains and plasmids used in these experiments and their sources are listed in Table 1 . Plasmid inserts are diagrammed in Fig. 5 .
Construction of plasmids. Plasmid pMG1 (see Fig. 5 ) was constructed by attaching BamHI linkers to the 210-bp HindIII-RsaI fragment of plasmid pSR1 (22) as described by Maniatis et al. (13) and digesting with BamHI, followed by ligation with BamHI-digested pKO1M (a derivative of pKO1 [15] for ampicillin-resistant (Ap) galK+ clones (red) on MacConkey-galactose agar plates. This plasmid is identical to pSU3 (24) except for minor differences in the polylinker region of the vector.
To convert the TaqI site of pMG1 into an XhoI site, pMG1 was digested with EagI and SmaI and ligated with a 274-bp EagI-TaqI fragment from plasmid pRD5 (Geever et al., unpublished data) and a 100-bp TaqI-Smal fragment from pMG1. After transformation, clones were selected and analyzed for the presence of a 274-bp EagI-XhoI spacer fragment. Since the TaqI site of the pRD5 fragment is preceded by a C nucleotide, ligation into the TaqI site of the pMG1 at -50 produces an XhoI site. One such plasmid, pSS1, was isolated and confirmed to have an XhoI site at -50 (see Fig.  5 ). Construction of pMS160, pSU3, pMS24, pSR1, pMS104, and pSC3 were described previously (21) (22) (23) (24) .
Preparation of crude protein extracts. All procedures were performed at 4°C unless otherwise indicated. E. coli and P. putida cells were grown at 37 and 30°C, respectively, in Luria broth (1% tryptone [Difco] , 0.5% yeast extract, 1% NaCl) with the appropriate antibiotics from an optical density at 600 nm of 0.05 to one of 0.5. Cells were harvested (10,000 x g for 15 min), washed once with incubation buffer (10 mM Tris hydrochloride, pH 7.5, 50 mM KCl, 1 mM EDTA, 0.5 mM dithiothreitol), and suspended in 2 volumes of incubation buffer. Cells were broken by sonication (Braunsonic microtip) in an ice bath for two 20-s intervals separated by a 20-s cooling period. Cell debris was removed by centrifugation at 10,000 x g for 15 min, and resultant cell-free extracts were frozen at -70°C. No (19) .
Analysis of activation of mutant sal promoters by NahR.
Mutant Ps.,-galK fusion plasmids (pEFPn) were transformed into E. coli S165(pMS104) containing the nahR gene on plasmid pMS104. Activation of mutant sal promoters by NahR and salicylate was then quantified by measuring galactokinase activity directed by fusion plasmids in cells grown with salicylate. Preparation of cell-free extracts and the assay procedure for galactokinase activity were described previously (24) .
Molecular biology techniques. Procedures for restriction enzyme digestions, ligations, transformations, electrophoresis, and electroelution were standard and have been described previously (13, 20, 21, 24) . DNA enzymes were used according to instructions of the manufacturers. Antibiotic levels utilized to select and maintain transformants were 100 pug of amicillin and 25 Rg of tetracycline per ml.
RESULTS
Demonstration of DNA-binding activity of the NahR protein. Various amounts of a crude protein extract of E. coli JM83(pMS15), which contains the cloned nahR gene on pUC9 (24) , were incubated in the presence of the inducer salicylate and a labeled 390-bp BstEII fragment which contains the nah operon promoter (22) . Electrophoresis of the reactions and autoradiographic analysis showed proteindependent mobility retardation of the labeled promoter fragment, suggesting that the E. coli strain with the cloned nahR gene contained a strong DNA-binding activity (Fig.  1A, lanes 1 to 4) . Extensive protein titration experiments showed that addition of increasing amounts of crude extract protein (0.1 to 5.0 Rg) resulted in an increasing proportion (10 to 100%) of the 390-bp nah promoter fragment that migrated at the retarded position (data not shown). At these protein concentrations the DNA-binding activity was totally absent from the parental E. coli JM83 strain lacking the nahR gene (Fig. 1A, lane 10) . Incubations containing identical amounts of a crude extract of E. coli JM83(pMS16) similarly showed no evidence of this DNA-binding activity (Fig. 1A,  lanes 8 and 9) . Plasmid pMS16 is identical to plasmid pMS15 except that an internal 400-bp fragment located within the nahR gene (24) has been deleted from the plasmid. Plasmid pMS16 does not activate nah operon expression in the presence of salicylate as does plasmid pMS15 (21, 24) . These results suggested that the DNA-binding activity observed by the mobility retardation assay was due to the presence of the NahR protein in E. coli JM83(pMS15) extracts. Use Analysis of NahR-binding activity in P. putida 277(NAH7).
To measure relative levels of NahR in its natural host, P. putida 277(NAH7) was used as the source of the crude protein extract for binding assays. Incubation of the 390-bp nah promoter fragment with 1 to 5 pLg of P. putida(NAH7) protein extract in the presence of salicylate showed a protein concentration-dependent binding activity (Fig. 1B, lanes 1 to  3) . In comparison, P. putida 277(NAH7::TnS/R23), which has a TnS insertion inactivating nahR (29) , showed no evidence of DNA-binding activity (Fig. 1B, lanes 6 and 7) with the same amount of extract protein. At protein levels of >20 pRg per 20-,u reaction, nonspecific binding activity was observed in all P. putida extracts (data not shown). As before, elimination of salicylate from the binding reaction or gel did not affect relative binding activity (Fig. 1B, lanes 2 to  5) . The apparent amount of binding activity observed with 5 ,ug of P. putida(NAH7) extract appears to be half that observed with 0.2 ,ug of E. coli JM83(pMS15) extract. This suggests that there is approximately 50-fold less NahR present in P. putida(NAH7) than in E. coli cells containing the cloned nahR gene. Growth of P. putida(NAH7) cells in the presence of the inducer salicylate did not alter the amount of DNA-binding activity observed in extracts (Fig.  1B, lane 8) , confirming constitutive expression of nahR in P. putida(NAH7) as reported previously (21, 22 (Fig. 2) . The apparent binding of NahR to the labeled 390-bp nah promoter fragment was completely eliminated by including in the binding reaction a 200-fold molar excess of unlabeled pSC3 plasmid DNA which contains the same 390-bp Pnah fragment on a cloned NAH7 DNA fragment in pUC9 (Fig. 2,  lane 3; Fig. 1B, lane 9) . A similar amount of added pUC9 vector DNA had no effect on the apparent binding activity for the 390-bp Pnah fragment (Fig. 2, lane 5) . However, addition of a 200-fold excess of pSR1 plasmid DNA, which contains Psal on a 800-bp Sall fragment of NAH7 cloned in pUC9, to the binding reaction also eliminated the apparent binding to the labeled 390-bp Pnah fragment (Fig. 2, lane 4 (Fig. 1B, lane 9 ; data not shown).
Previous experiments have shown that the sal promoter sequence between -83 and -45 is required for NahR to mediate salicylate-dependent activation of transcription (24) . Analogous results were obtained in a DNA-binding analysis utilizing the mobility retardation assay and promoter deletion fragments (23) . A 305-bp EcoRV-EcoRI fragment of pMS160 which contains the sal promoter sequence between -83 and +27 (see Fig. 4 and 5) was bound tightly by the NahR present in the E. coli(pMS15) extracts, while a 265-bp fragment of pMS24 which contains the sal promoter sequence between only -45 and +27 (see Fig. 4 Fig. 6A . These data suggested that NahR binds at least 50-fold less to DNA fragments lacking the -83 to -45 sequence; thus, this region is apparently required for both transcription activation and NahR binding. These data also suggested that the sal promoter sequence between -83 and -45 contained at least part of the binding site for NahR.
Determination of NahR-binding site. To confirm the suggested location of the NahR-binding site and to further localize the nucleotides involved in binding, DNase I protection experiments were performed. NahR was partially purified from E. coli(pMS15) cells by utilizing the mobility retardation assay to monitor purification. After fractionation of a crude extract of E. coli(pMS15) by ammonium sulfate precipitation and DEAE-cellulose chromatography, the specific activity of the preparation (in terms of Pnah binding activity) was increased approximately sevenfold. This partially purified preparation was incubated with 3'-end-labeled fragments containing either Pnah or PsaI, followed by partial DNase I treatment and polyacrylamide gel electrophoresis (Fig. 3) . Incubation of the Psa, fragment with the NahR protein preparation resulted in the protection of the region between -80 and -48 before the transcription start site of the sal operon from DNase I digestion (Fig. 3a, lane B) . Similarly, incubation of the Pnah fragment with the NahR protein preparation resulted in protection of the region between -82 and -47 before the transcription start site (Fig.  3b, lane D) . The position of the protected region (relative to the transcription start site) is nearly identical for both promoters ( Fig. 4A and B) . Addition of salicylate to the binding reaction did not drastically affect the location of the protected region (Fig. 3a, lane C; Fig. 3b, lane C) . Although Fig. 3 shows some minor changes in the nucleotide protection patterns of the salicylate-containing reactions, these were not consistently reproducible and may not be significant. Experiments with purified E. coli RNA polymerase or fractionated extract from the nahR deletion strain E. coli(pMS16) (Fig. 3a, lanes D and E; Fig. 3b , lanes E and F) did not produce any significant protection of either promoter fragment and indicate that the observed protection is NahR specific. Although the footprinting was performed with relatively crude preparations of NahR, the bulk of the in vitro and in vivo data suggests that the nahR gene product specifically binds to and protects the -82 to -47 region of both the nah and sal promoters and does not require the presence of the inducer for binding. The DNA sequences within these two regions of the promoters are highly homologous and suggest a consensus NahR-binding site (Fig. 4) .
Analysis of individual nucleotides involved in transcription activation. To and nahR (on pMS104) were induced to 17 U/mg of protein by salicylate, while levels directed by pMG1 (with wild-type Psad) were induced to 22 U/mg of protein ( Table 2 ). The binding affinity of NahR for promoter fragments from pEFP86 and pMG1 appeared to be identical (Fig. 6A, lanes  3 and 4 versus lanes 9 and 10; Fig. 6C, lanes 1 to 4 versus  lanes 8 to 11) . Thus, the mutant sal promoter on pEFP86 does not behave differently from the wild-type sal promoter. The conclusion that the nucleotide change at -50 is not functionally significant is also supported by the fact that, in the wild-type sequence of the homologous nah promoter (22) , the nucleotide at this same position is also C (Fig. 4B) . In further analysis and discussion, plasmid pEFP86 is considered to be phenotypically wild type.
Nine Psal-galK fusion plasmids, identical to pEFP86 except that they contained unique single-nucleotide change mutations between -80 and -58, were obtained by cloning degenerate sequence NahR-binding sites into pSS1. The structures of the resultant plasmids are shown in Fig. 5 . The effect of the mutations in the NahR-protected region on transcription activation of the sal promoter was determined by measuring galactokinase activity produced by each mutant plasmid in the presence of the nahR gene and the inducer salicylate (Table 2 ). Only two of the nine single nucleotide mutations resulted in very dramatic changes in ability of Psa, to be activated by nahR. Two adjacent mutations, in plasmids pEFP90 and pEFP88 (A-RC at -74 and T-EA at -73, respectively; Fig. 5 ), caused at least a 30-fold reduction in the ability of Psal to be activated by NahR and salicylate ( Table 2 ). The lack of significant activation is similar to what occurs with the fusion plasmid pMS24, which has the NahR-binding site deleted. Thus, these two adjacent nucleotides are apparently essential for activation of Psal by the nahR gene product.
One other mutation, in pEFP96 (T--G at -66), also affected the ability of Psal to be activated by NahR, but to a much lesser extent. This mutation reduced activation by 65% but still permitted a 4.5-fold induction by NahR. All other mutants analyzed (pEFP98, T-EA at -69; pEFP104, T-I*C at -67; pEFP100, A-NT at -64; pEFP70, G-OT at -62; pEFP74, T-OG at -59; Fig. 5 ) had only minor effects (<50% reduction) on NahR-mediated activation. These mutants could be induced >eightfold by NahR and salicylate. Apparently these nucleotides are not absolutely critical to Psal for its activation by NahR.
Effects of mutations on binding of NahR. The mutant binding sites on these fusion plasmids were analyzed for their relative binding affinity for NahR. Standard gel mobility shift assays were performed with extracts from E. coli(pMS15) utilizing 32P-labeled pMG1 DNA digested with EcoRI in the presence of a 200-fold molar excess of unlabeled EcoRI-digested DNA from each mutant fusion plasmid (Fig. 6A) . The presence of excess unlabeled DNA with near-wild-type affinity for NahR (e.g., pMG1, pMS160, and pEFP86; Fig. 6A , lanes 3 to 4 and 7 to 10) dramatically reduced the apparent amount of retarded labeled fragment by outcompeting the labeled wild-type promoter fragment for NahR binding. If the unlabeled DNA has very low affinity for NahR (e.g., pMS24; Fig. 6A, lanes 5 and 6) , there is little or no effect on the amount of bound labeled fragment with retarded mobility.
Analysis of relative NahR-binding affinities of all of the single-nucleotide change sal promoter mutants with this type of competition binding analysis is shown in Fig. 6B . Unlabeled DNA from all mutants which were not dramatically reduced in ability to be activated by nahR and salicylate showed effective competition with the labeled wild-type promoter fragment from pMG1, demonstrating a near-wildtype binding affinity for NahR. However, DNA from plasmids pEFP88 and pEFP90 had very little effect on binding of NahR to the labeled wild-type promoter fragment, indicating that these promoters have very low affinity for NahR. Direct measurements of binding of NahR to labeled promoter fragments from pEFP88 and pEFP90 (Fig. 6C, have an unusual phenotype. The mutation (C-UT at -80) in pEFP80 resulted in nearly constitutive expression of galK from the mutant promoter (Table 2 , last line). The levels of galK expression in both the presence and absence of salicylate were close to the fully induced levels directed by the parent plasmid pEFP86. Thus, this mutation resulted in a >10-fold increase in the uninduced levels of PsaI expression. (24) . In pSS1 the EagI-TaqI fragment of pMG1 has been replaced by an EagI-XhoI spacer DNA fragment. The sequence of the NahR-protected region (-85 to -45; EagI to XhoI) inserted into pSS1 to produce pEFP86 is illustrated, and the single-nucleotide difference A-C at -50 between pMG1 and pEFP86 is marked with an asterisk. Arrows up and down from this sequence show the location and nature of the single-nucleotide changes in the NahR-binding sites of each of the mutants (pEFP80, pEFP90, etc). (+), Transcription start site of Psal; RBS, putative ribosome-binding site (22) . Box indicates the region protected by NahR. Restriction sites were as follows: R, EcoRI; A, RsaI; E, EagI; T, TaqI; X, XhoI; S, SalI. The complete nucleotide sequence of the illustrated regions (-100 to +1) is shown in Fig. 4A . (Fig. 6) . +, Near-wild-type binding affinity for NahR; -, no detectable binding of NahR.
Binding analysis showed that the apparent binding affinity of NahR for the mutant binding site on pEFP80 was similar to that of pEFP86 (Fig. 6C, lanes 16 to 19) 
